Submissions from 2020
Second-line lenvatinib in patients with recurrent endometrial cancer, Ignace Vergote, Matthew A. Powell, Michael G. Teneriello, David S. Miller, Agustin A. Garcia, Olga N. Mikheeva, Mariusz Bidzinski, Cristina Ligia Cebotaru, Corina E. Dutcus, Min Ren, Tadashi Kadowaki, Yasuhiro Funahashi, and Richard T. Penson
Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis, Mary E. Westerman, Andrea Kokorovic, Xin Shelly Wang, Amy Lim, Araceli Garcia-Gonzalez, Mohamed Seif, Run Wang, Ashish M. Kamat, Colin P. Dinney, and Neema Navai
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models, Mary E. Westerman, Daniel D. Shapiro, Nizar M. Tannir, Matthew T. Campbell, Surena F. Matin, Jose A. Karam, and Christopher G. Wood
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma, Mary E. Westerman, Daniel D. Shapiro, Christopher G. Wood, and Jose A. Karam
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study, Anna H. Wu, Chiuchen Tseng, Cheryl Vigen, Yang Yu, Wendy Cozen, Agustin A. Garcia, and Darcy Spicer
Submissions from 2018
Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination, Andrew G. Chapple and Peter F. Thall